Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Corticotroph Tumor Progression after Adrenalectomy in Cushing’s Disease: A Reappraisal of Nelson’s Syndrome
2006
Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54
2003 Standout
Stress Hormone-Related Psychopathology: Pathophysiological and Treatment Implications
2001
Long-Term Mortality after Transsphenoidal Surgery and Adjunctive Therapy for Acromegaly1
1998
Outcome of Cushing's Disease following Transsphenoidal Surgery in a Single Center over 20 Years
2012
Reversal of acromegalic cardiomyopathy in young but not in middle‐aged patients after 12 months of treatment with the depot long‐acting somatostatin analogue octreotide
2003
Acromegaly
2006 Standout
Final adult height and body mass index after cure of paediatric Cushing's disease
2005
Echocardiographic evidence for a direct effect of GH/IGF‐I hypersecretion on cardiac mass and function in young acromegalics
1998
Mortality and Cancer Incidence in Acromegaly: A Retrospective Cohort Study1
1998
Diurnal Rhythm of Plasma Catecholamines in Acromegaly1
1999
Larger Thigh and Hip Circumferences Are Associated with Better Glucose Tolerance: The Hoorn Study
2003
COLON CANCER AND POLYPS IN ACROMEGALY: INCREASED RISK ASSOCIATED WITH FAMILY HISTORY OF COLON CANCER
1990
Cardiac Effect of Thyrotoxicosis in Acromegaly1
2000
Ultrasensitive deletion detection links mitochondrial DNA replication, disease, and aging
2020
Waist circumference and not body mass index explains obesity-related health risk
2004 Standout
Body fat distribution, insulin resistance, and metabolic diseases
1997
Perceived discrimination and health: A meta-analytic review.
2009 Standout
Loss of Body Cell Mass in Cushing’s Syndrome: Effect of Treatment
2002
Adrenal Localization in the Adrenocorticotropic Hormone-Independent Cushing Syndrome
1988
Cardiovascular involvement in patients affected by acromegaly: An appraisal
2012
Use of doping agents, particularly anabolic steroids, in sports and society
2008 Standout
Acromegaly: Re-thinking the cancer risk
2007
Risk of colorectal neoplasm in patients with acromegaly: A meta-analysis
2008
Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study
2005 Standout
Cushing's syndrome
2015 Standout
Genetic analysis of 29 kindreds with generalized and pituitary resistance to thyroid hormone. Identification of thirteen novel mutations in the thyroid hormone receptor beta gene.
1994
Phaeochromocytoma
2005 Standout
Hallmarks of aging: An expanding universe
2023 Standout
Is the Acromegalic Cardiomyopathy Reversible? Effect of 5-Year Normalization of Growth Hormone and Insulin-Like Growth Factor I Levels on Cardiac Performance*
2001
Regional differences of insulin action in adipose tissue: insights from in vivo and in vitro studies
2005
Outcome of surgery for acromegaly--the experience of a dedicated pituitary surgeon
1999
Premature mortality due to cardiovascular disease in hypopituitarism
1990 Standout
Adipocytes as regulators of energy balance and glucose homeostasis
2006 StandoutNature
Nelson's syndrome
2010
The Nelson's syndrome... revisited
2004
Occupational Status, Cortisol Secretory Pattern, and Visceral Obesity in Middle‐aged Men
2000
Human growth hormone doping in sport
2006
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
2017 Standout
Hormonal and Metabolic Effects of Radiotherapy in Acromegaly: Long-Term Results in 128 Patients Followed in a Single Center
2000
Diabetes in acromegaly, prevalence, risk factors, and evolution: data from the French Acromegaly Registry
2011
Growth Hormone Deficiency in Adulthood and the Effects of Growth Hormone Replacement: A Review
1998
Early Vascular Alterations in Acromegaly
2002
Assessment of Disease Activity in Treated Acromegalic Patients Using a Sensitive GH Assay: Should We Achieve Strict Normal GH Levels for a Biochemical Cure?
2002
Serum lipoprotein changes following IGF‐I normalization using a growth hormone receptor antagonist in acromegaly
2002
Does the GH–IGF axis play a role in cancer pathogenesis?
2000
Primary medical therapy for acromegaly
2003
Growth hormone, IGF-I and cancer. Less intervention to avoid cancer? More intervention to prevent cancer?
1999
Body Weight and Body Composition Changes after Treatment of Hyperthyroidism1
1998
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
1997 StandoutNature
Epidemiology of Acromegaly
1999
Excess mortality for patients with residual disease following resection of pituitary adenomas
2011
External review and validation of the Swedish national inpatient register
2011 Standout
Increased arterial intima‐media thickness by B‐M mode echodoppler ultrasonography in acromegaly
2001
Insulin and insulin-like growth factor signalling in neoplasia
2008 Standout
Sex differences in HPA axis responses to stress: a review
2004 Standout
LONG‐TERM FOLLOW‐UP OF LOW‐DOSE EXTERNAL PITUITARY IRRADIATION FOR CUSHING'S DISEASE
1990
Central and peripheral actions of somatostatin on the growth hormone–IGF-I axis
2004
Acromegaly
1994
Relationship between blood pressure and glucose tolerance in acromegaly
2001
Sleep Apnea in Acromegaly
1991
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
2004 Standout
Characterization of premature atherosclerosis of carotid arteries in acromegalic patients
2001
CLINICAL PERSPECTIVE: Acromegaly and Cancer: Not a Problem?
2001
Human Growth Hormone and Human Aging
1993
Acromegaly: An Endocrine Society Clinical Practice Guideline
2014 Standout
A unifying pathway for essential hypertension
2005
Diagnosis and Complications of Cushing’s Syndrome: A Consensus Statement
2003 Standout
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
2008 Standout
Behavior and metabolic disease
1996
Monogenic Disorders of Puberty
2002
Serum lipoproteins in acromegaly before and 6‐15 months after transsphenoidal adenomectomy
1994
Nutrition, hormones, and breast cancer: Is insulin the missing link?
1996
Acromegaly and gastrointestinal cancer
1991
Hypothalamic Origin of the Metabolic Syndrome X
1999
Cerebrovascular mortality in patients with pituitary adenoma
2002
Fetal nutrition and cardiovascular disease in adult life
1993 Standout
The incidence of thyroid disorders in the community: a twenty‐year follow‐up of the Whickham Survey
1995 Standout
Management of Chronic Kidney Disease Patients in the Intensive Care Unit: Mixing Acute and Chronic Illness
2017 Standout
Growth-hormone and prolactin excess
1998
Determinants of Survival in Treated Acromegaly in a Single Center: Predictive Value of Serial Insulin-Like Growth Factor I Measurements
2004
Vascular reactivity in acromegalic patients: preliminary evidence for regional endothelial dysfunction and increased sympathetic vasoconstriction
2000
A Nationwide Survey of Mortality in Acromegaly
2005
Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under‐recognized and under‐diagnosed
2009
Twenty-four hour profile of blood pressure in patients with acromegaly. Correlation with demographic, clinical and hormonal features
1999
CLINICAL PERSPECTIVE: Acromegaly and Cancer: A Problem
2001
Determinants of clinical outcome and survival in acromegaly
1994
A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
1998 StandoutNature
Clinical aspects of SDHx-related pheochromocytoma and paraganglioma
2009
Adipocyte differentiation from the inside out
2006 Standout
Cardiac Involvement in Acromegaly: Specific Myocardiopathy or Consequence of Systemic Hypertension?1
1997
TRANSSPHENOIDAL SURGERY FOR CUSHING'S DISEASE: DOES WHAT IS REMOVED DETERMINE THE ENDOCRINE OUTCOME?
1990
Cushing's syndrome
2006 Standout
Induction of mammary adenocarcinomas in metallothionein promoter‐human growth hormone transgenic mice
1991
Computed tomography assessment of fat distribution in male and female patients with Cushing's syndrome
2003
Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice.
1997
Socioeconomic Status and Obesity
2007 Standout
A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly
2008
Growth Hormone and the Heart
1994
Factors Influencing Mortality in Acromegaly
2004
Self Image and Quality of Life in Acromegaly
2002
If it goes up, must it come down? Chronic stress and the hypothalamic-pituitary-adrenocortical axis in humans.
2007 Standout
The Wisconsin Epidemiologic Study of Diabetic Retinopathy
1987 Standout
Systemic Hypertension and Impaired Glucose Tolerance Are Independently Correlated to the Severity of the Acromegalic Cardiomyopathy1
2000
Gender- and age-related differences in the endocrine parameters of acromegaly
2002
Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA)
2004
Acromegaly: An epidemiological study
1993
Assessment of long-term remission of acromegaly following surgery
2003
Gender and age influence the relationship between serum GH and IGF‐I in patients with acromegaly
2002
Impact of Gender, Menstrual Cycle Phase, and Oral Contraceptives on the Activity of the Hypothalamus-Pituitary-Adrenal Axis
1999 Standout
The effects of long-term growth hormone treatment on cardiac left ventricular dimensions and blood pressure in girls with Turner’s syndrome
1999
Hypertension in patients with cushing’s disease: Pathophysiology, diagnosis, and management
2005
Adipose Tissue as an Endocrine Organ
2004 Standout
Treatment of acromegaly: is there still a place for radiotherapy?
2007
Effects of 1-Year Treatment with Octreotide on Cardiac Performance in Patients with Acromegaly
1999
The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes
2003 Standout
Pituitary Tumor Registry: A Novel Clinical Resource1
2000
Waist and hip circumferences have independent and opposite effects on cardiovascular disease risk factors: the Quebec Family Study
2001
Colonoscopic Screening and Follow-Up in Patients with Acromegaly: A Multicenter Study in Italy
2005
Can Meditation Slow Rate of Cellular Aging? Cognitive Stress, Mindfulness, and Telomeres
2009 StandoutNobel
Bioelectrical impedance analysis?part I: review of principles and methods
2004 Standout
Stereotactic radiosurgery for recurrent surgically treated acromegaly: comparison with fractionated radiotherapy
1998
Hormonal regulation of longevity in mammals
2007
Growth hormone as a risk for premature mortality in healthy subjects: data from the Paris prospective study
1998
Radiosurgery of growth hormone–producing pituitary adenomas: factors associated with biochemical remission
2007
Occurrence of ventricular late potentials in patients with active acromegaly
2001
Muscle Sympathetic Nerve Activity in Patients with Acromegaly
2000
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human*
1998 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
AN EVALUATION OF LABORATORY TESTS FOR THE DETECTION AND DIFFERENTIAL DIAGNOSIS OF CUSHING'S SYNDROME
1977
Low density lipoprotein cholesterol: An association with the severity of diabetic retinopathy
1982
Growth Hormone Receptor Antagonists: Discovery, Development, and Use in Patients with Acromegaly
2002
Impact of Patient’s Age and Disease Duration on Cardiac Performance in Acromegaly: A Radionuclide Angiography Study
1999
Management of growth hormone deficiency in adults
2007
Mortality in Acromegaly: A Metaanalysis
2007
Clinical Manifestations of Acromegaly
1992
Atrophy of Skeletal Muscle in Patients With Cushing's Syndrome
1970
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
2004 Standout
Improved Glucose Tolerance with High Carbohydrate Feeding in Mild Diabetes
1971
Dual Sites of Inhibition by Metyrapone of Human Adrenal Steroidogenesis: Correlation ofin Vivoand andin VitroStudies
1976
Relationship between Disease-Related Morbidity and Biochemical Markers of Activity in Patients with Acromegaly
2005
Results of Treating Childhood Cushing's Disease with Pituitary Irradiation
1977
Pheochromocytoma: implications in tumorigenesis and the actual management.
2012
Physiological and Molecular Basis of Thyroid Hormone Action
2001 Standout
The Cushing Syndromes: Changing Views of Diagnosis and Treatment
1979
Basal- and insulin-stimulated substrate metabolism in patients with active acromegaly before and after adenomectomy.
1992
Mortality in Patients with Pituitary Disease
2010
Thyroid Hormone Regulation of Metabolism
2014 Standout
Spontaneous Remission of Cushing's Disease
1967
Body composition. Prediction of normal body potassium, body water and body fat in adults on the basis of body height, body weight and age
1980
The prevalence of colonic polyps in acromegaly: a colonoscopic and pathological study in 103 patients.
1995
Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific Statement
2013 Standout
Tumor Recurrence and Hypertension Persistence After Successful Pheochromocytoma Operation
1997
Risk factors and long-term outcome in pituitary-dependent Cushing's disease.
1996
LONG‐TERM RESULTS OF ADRENAL SURGERY IN PATIENTS WITH CUSHING'S SYNDROME DUE TO ADRENOCORTICAL ADENOMA
1984
Hypertension in acromegaly and in the normal population: prevalence and determinants
2005
Cardiovascular Effects of Depot Long-Acting Somatostatin Analog Sandostatin LAR in Acromegaly*
2000
Is visceral obesity a physiological adaptation to stress?
2003
ECTOPIC FUNCTIONING ADRENOCORTICO‐MYELOLIPOMA IN LONGSTANDING NELSON'S SYNDROME
1979
Cushing's syndrome: A review of diagnostic tests
1979
The Metabolic Syndrome
2008 Standout
Sertoli-Sertoli and Sertoli-Germ Cell Interactions and Their Significance in Germ Cell Movement in the Seminiferous Epithelium during Spermatogenesis
2004 Standout
Succinate Dehydrogenase B Gene Mutations Predict Survival in Patients with Malignant Pheochromocytomas or Paragangliomas
2007
Male Contraception
2002
Protein Glycoengineering Enabled by the Versatile Synthesis of Aminooxy Glycans and the Genetically Encoded Aldehyde Tag
2011 StandoutNobel
SERUM TRIIODOTHYRONINE AND HYPERTHYROIDISM IN A POPULATION SAMPLE OF WOMEN
1984
Transsphenoidal Microsurgery for Growth Hormone-Secreting Pituitary Adenomas: Initial Outcome and Long-Term Results
1998
The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline
2008 Standout
Mutations of Gonadotropins and Gonadotropin Receptors: Elucidating the Physiology and Pathophysiology of Pituitary-Gonadal Function
2000
Renal Injury and Salt-Sensitive Hypertension After Exposure to Catecholamines
1999
Extending Healthy Life Span—From Yeast to Humans
2010 StandoutScience
Cardiovascular Function in Acromegaly
2003
Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline
2014 Standout
Glucocorticoids Down-Regulate Glucose Uptake Capacity and Insulin-Signaling Proteins in Omental But Not Subcutaneous Human Adipocytes
2004
Octreotide as Primary Therapy for Acromegaly
1998
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
2008 Standout
Works of Ingrid Ernest being referenced
Follitropin (FSH) Deficiency in an Infertile Male due to FSHβ Gene Mutation. A Syndrome of Normal Puberty and Virilization but Under-developed Testicles with Azoospermia, Low FSH but High Lutropin and Normal Serum Testosterone Concentrations
1998
Epidemiology and Long‐term Survival in Acromegaly: A Study of 166 Cases Diagnosed between 1955 and 1984
1988
Long‐term Results in 64 Patients Operated Upon for Pheochromocytoma
1988
Changes in body composition and adipose tissue distribution after treatment of women with Cushing's syndrome
1994
Adrenalectomy in Cushing's disease. A long-term follow-up.
1972
ADRENALECTOMY IN CUSHING'S DISEASE
1972
Thyroid hormone resistance in a 35-year old man with recurrent goitre
1982
STEROID EXCRETION AND PLASMA CORTISOL IN 41 CASES OF CUSHING'S SYNDROME
1966
Carbohydrate-rich, fat-poor diet in diabetes
1965
Adrenal scintigraphy in Cushingʼs syndrome caused by bilateral hyperplasia, adenoma or carcinoma
1985
Thyroid hormone resistance in a 35-year old man with recurrent goitre
1982
CHANGES IN BODY COMPOSITION AFTER THERAPEUTICALLY INDUCED REMISSION IN 12 CASES OF CUSHING'S SYNDROME
1967